"We thank Exelixis for their generous support of our Jacksonville Patient Symposium"
Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers.
"We thank Prometheus for their generous support of our Regional Clinical Trials Initiatives"
Prometheus is committed to improving lives through the development and commercialization of novel pharmaceutical and diagnostic products that enable physicians to provide greater individualized patient care. Our strategy includes the marketing and delivery of proprietary diagnostic testing services, scientific nutritional solutions and pharmaceutical products
"A special thank you to Pfizer for supporting our Patient Support Speaker series Initiatives"
Pfizer is grounded in our belief that all people deserve to live healthy lives. This drives our desire to provide access to medicines that are safe, effective, and affordable.